Medical Marijuana For Staph & Other Ailments (GFON)
It is hard to imagine that there are now two medical-related marijuana companies that are public stocks. But that is the new world for you. Cannabis Science, Inc. (OTCBB: GFON) has a report on the current state of research into the use of natural plant cannabinoids to reduce the spread of drug-resistant bacteria, including methicillin-resistant Staphyloccus aureus (MRSA), and the prospects for development of topical whole-cannabis treatments.
The company noted a Journal of the American Medical Association and a Center for Disease Control in 2007 report, showing that MRSA is responsible for more than 18,500 hospital-stay related deaths each year, and increased direct healthcare costs of as much as $9.7 billion.
Dr. Melamede, chief scientist and director at Cannabis Science, Inc., noted that research into use of whole cannabis extracts and multi-cannabinoid compounds has provided the scientific rationale for medical marijuana’s efficacy in treating some of the most troubling diseases mankind now faces. What is interesting is that the reference was made to infectious diseases such as the flu and HIV, autoimmune diseases such as ALS, multiple sclerosis, arthritis, diabetes, neurological conditions such as Alzheimer’s, stroke and brain injury, and numerous forms of cancer.
The company also noted that investigators at Italy’s Universita del Piemonte Orientale and Britain’s University of London School of Pharmacy reported in the Journal of Natural Products that five cannabinoids – THC, CBD, CBG, CBC, and CBN – showed potent antibacterial activity and exceptional antibacterial activity against two epidemic MRSA occurring in UK hospitals.
Keep in mind that this is not direct news from the company itself. The company is recently public and you can probably be assured that there will be many more “reference” press releases similar to this.
Here was the announcement at 24/7 Wall Street that Cannibis Science, Inc. (OTCBB: GFON) was now public. And here is the announcement about another player coming public called Medical Marijuana, Inc. (OTC: CVIV), formerly Club Vivanet.
JON C. OGG